Hematology & Oncology Doctors in Hackensack, NJ Accepting Medicare

6 Hematology & Oncology doctors found. Showing 1 - 6

Joanna P Mohney, AGPCNP-BC Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-5863

Dr. Carrie Brooke Wasserman, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 92 Second Street, Hackensack, NJ 07601 Phone: 551-996-5900    Fax: 551-996-9246

Danielle Elizabeth Marcotulli, APN Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 92 2nd St Ste 3, Hackensack, NJ 07601 Phone: 519-963-9255

Christina Cho, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-5855

Dr. Kristina Krstanoska, DNP, RN, AGPCNP-BC Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 92 2nd St # 210, Hackensack, NJ 07601 Phone: 551-995-3925

Richard J Rosenbluth, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 201-996-5818    Fax: 551-996-0577

News Archive

Dextran-coated onto iron oxide nanoparticles can detect cholera toxin: Study

A complex sugar may someday become one of the most effective weapons to stop the spread of cholera, a disease that has claimed thousands of lives in Haiti since the devastating earthquake last year.

SNX-5422 could make an effective COVID-19 prophylactic, says study

SNX-5422 is a heat shock protein 90 (Hsp90) inhibitor currently undergoing clinical trials as a cancer therapeutic. A recent study examines the applicability of repurposing the drug towards severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication inhibition.

Scientists cast doubt on value of screening for prostate cancer

Even though deaths from prostate cancer death have fallen in the U.S. since screening became more common, new research is suggesting that this does not justify the need for such tests.

Tackling Zika virus: Challenges ahead

Health officials, drug companies, governments and the public are scrambling to understand and combat the Zika virus. The virus was first identified almost 70 years ago, but little is known about it. And now, officials suspect it could be related to a rise in microcephaly cases in affected countries.

Pain, embarrassment, and lack of time, major reasons for women not electing breast cancer screening

While breast cancer screening in rural America remains underutilized, barriers to screening mammography in poor, rural areas are marked by significant racial disparities, according to a new study.

Read more Medical News

› Verified 4 days ago